Many US biotechs lack ESG disclosure, study finds
Many US biotech companies have ‘limited or no explicit ESG disclosure’ despite recognizing the growing importance of...
Read More
Energy sector investors place greater weight on some challenges posed by the new-energy transition than do corporate executives...
Virtual meetings became the standard during the Covid-19 pandemic out of necessity and, with uncertainty over when the pandemic...
Many companies are setting ambitious environmental targets and are confident about their understanding of the issues – but are...
Thirty-six percent of investors say they support divestment as a tool against climate change, up from 30 percent before COP26...